Aplastic Anemia Clinical Pathway — All Settings
Aplastic Anemia Clinical Pathway — All Settings
Equine ATG Therapy Protocol
This regimen is recommended for the pharmacologic treatment of newly diagnosed aplastic anemia.
Treatment Recommendations
*If weight on orders differ by more than 5% from admission weight, contact attending MD for additional instructions.
Pharmacologic Element | Dosage | Special Instructions |
---|---|---|
Anti-thymocyte Globulin, Equine (ATG) | 40 mg/kg on Day 1, 2, 3, 4 |
|
Cyclosporine |
|
Target trough blood level 150-300 ng/ml Ensure that patient receives “Neoral” not generic substitute |
Methylprednisolone or Prednisone |
|
Switch to PO on discharge @ same dose. Begin 2 week taper on day 10 (since initiation) |
H2 Blocker: Famotidine | Refer to Formulary – Famotidine | Continue while on steroids. |
Pentamidine | Refer to Formulary – Pentamidine | For duration: Refer to Antimicrobial Stewardship Guidelines |
Voriconazole | Refer to Formulary – Voriconazole | Should be initiated at the time of immunosuppressive therapy For duration: Refer to Antimicrobial Stewardship Guidelines |
G-CSF | Starting dose: 5 mcg/kg/dose SQ, titrate as clinically needed Daily maximum dose: 480 mcg/day |
|
*For special instructions or further information about ordering at CHOP, please see internal link.